GPR30 is Associated With Major Depressive Disorder

被引：0
|
作者：
Ramikie, Teniel [1 ]
Guffanti, Guia [1 ]
Stevens, Jennifer [1 ]
Ressler, Kerry [1 ]
机构：
[1] Harvard Med Sch, McLean Hosp, Belmont, MA USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2017年 / 42卷
关键词：
Major Depression Disorder; Sex Steroids; Amygdala;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T22
引用
收藏
页码：S307 / S308
页数：2
相关论文
共 50 条
  • [21] Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30
    Revankar, Chetana M.
    Mitchell, Hugh D.
    Field, Angela S.
    Burai, Ritwik
    Corona, Cesear
    Ramesh, Chinnasamy
    Sklar, Larry A.
    Arterburn, Jeffrey B.
    Prossnitz, Eric R.
    ACS CHEMICAL BIOLOGY, 2007, 2 (08) : 536 - 544
  • [22] GPR30: A G protein-coupled receptor for estrogen
    Prossnitz, Eric R.
    Arterburn, Jeffrey B.
    Sklar, Larry A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2007, 265 : 138 - 142
  • [23] The Correlation Between GPR30 and Clinicopathologic Variables in Breast Carcinomas
    Tu, Gang
    Hu, Dingrong
    Yang, Guanglun
    Yu, Tinghe
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (03) : 231 - 234
  • [24] GPR30 contributes to estrogen-induced thymic atrophy
    Wang, Chunhe
    Dehghani, Babak
    Magrisso, I. Jack
    Rick, Elizabeth A.
    Bonhomme, Edna
    Cody, David B.
    Elenich, Laura A.
    Subramanian, Sandhya
    Murphy, Stephanie J.
    Kelly, Martin J.
    Rosenbaum, Jan S.
    Vandenbark, Arthur A.
    Offner, Halina
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (03) : 636 - 648
  • [25] Virtual and biomolecular screening converge on a selective agonist for GPR30
    Cristian G Bologa
    Chetana M Revankar
    Susan M Young
    Bruce S Edwards
    Jeffrey B Arterburn
    Alexander S Kiselyov
    Matthew A Parker
    Sergey E Tkachenko
    Nikolay P Savchuck
    Larry A Sklar
    Tudor I Oprea
    Eric R Prossnitz
    Nature Chemical Biology, 2006, 2 : 207 - 212
  • [26] GPR30, Mineralocorticoid Receptors, and the Rapid Vascular Effects of Aldosterone
    Funder, John W.
    HYPERTENSION, 2011, 57 (03) : 370 - 372
  • [27] Virtual and biomolecular screening converge on a selective agonist for GPR30
    Bologa, CG
    Revankar, CM
    Young, SM
    Edwards, BS
    Arterburn, JB
    Kiselyov, AS
    Parker, MA
    Tkachenko, SE
    Savchuck, NP
    Sklar, LA
    Oprea, TI
    Prossnitz, ER
    NATURE CHEMICAL BIOLOGY, 2006, 2 (04) : 207 - 212
  • [28] A critical review of fundamental controversies in the field of GPR30 research
    Langer, Gernot
    Bader, Benjamin
    Meoli, Luca
    Isensee, Joerg
    Delbeck, Martina
    Noppinger, Patricia Ruiz
    Otto, Christiane
    STEROIDS, 2010, 75 (8-9) : 603 - 610
  • [29] GPR30 mediates estrogen rapid signaling and neuroprotection (Reprinted)
    Tang, Hui
    Zhang, Quanguang
    Yang, Licai
    Dong, Yan
    Khan, Mohammad
    Yang, Fang
    Brann, Darrell W.
    Wang, Ruimin
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 389 (1-2) : 92 - 98
  • [30] GPR30 Novel Therapeutic Target for Type 2 Diabetes
    Kumar, Rajesh
    Balhusizen, Alexander
    Salehi, Albert
    DIABETES, 2010, 59 : A444 - A444
12345